CClinicalTrials.gg
CompletedNCT00275600Updated Nov 26, 2009

Randomized Clinical Trial of Vitamin E and Evening Oil of Primrose for the Managment of Breast Pain

A Phase 2/3 interventional study of Vitamin E, Evening Oil of Primrose, and Placebo in Cyclical Breast Pain, sponsored by Mayo Clinic. Completed at 1 site in United States. Open to female participants aged 18 Years to 56 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2009-11-26.

Sponsored by Mayo Clinic · Phase 2/3, Interventional, and Treatment

Phase
Phase 2/3
Study type
Interventional
Enrollment
82
Allocation
Randomized
Ages
18 Years to 56 Years
Sex
Female
01

Study summary

This study is being done to find out what effects Vitamin E or Evening Oil of Primrose has on cyclical breast pain.

Read the detailed description

Cyclical mastalgia is a common complaint of women presenting to their primary care physicians. Cyclical breast pain is defined as prementstrual breast discomfort associated with hormonal fluctuations during the menstrual cycle. A clinical breast examination and sometimes additional imaging, such as sonography or mammography, is required as part of the evaluation to exclude malignancy. For most women, the symptoms are effectively managed with reassurance and conservative treatment measures such as the use of a supportive bra or over the counter pain medication such as acetaminophen or anti-inflammatories. However, a small number of women will require additional drug treatment with danazol after failing to respond to conservative measures. Unfortunately, danazol is associated with significant side effects. In the Mayo Breast Clinic, women with cyclical breast pain are managed with Vitamin E and Evening oil of primrose (EOP) either as single agents or in combination. These over the counter supplements are readily available, acceptable due to minial side effects and appear to lead to significant reduction in breast pain. We propose a randomized placebo controlled trial to determine if any vitamin E or EOP or the combination of both are effective in managing cyclical breast pain.

02

Conditions studied

  • Cyclical Breast Pain

Browse trials for

03

In context

Mastodynia

54 studies on the registry are indexed under Mastodynia; 10 are open to participants now.

This study's enrollment of 82 is above the median of 65 across 42 interventional studies indexed under Mastodynia.

Browse Mastodynia studies →

Lead sponsor

Mayo Clinic is the lead sponsor of 3,218 studies on the registry; 670 are open to participants now.

Of its 445 completed or terminated interventional studies of FDA-regulated products, 313 (70%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 56 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes

Eligibility criteria

Inclusion Criteria:

  • 18 years or older
  • premenopausal
  • cyclical breast pain
  • breast pain survey indicating 3 or more on scale of 1-10
  • if > 40 years of age, need normal mammogram and/or ultrasound if indicated and if not done within the last year
  • if \< 40 years of age, a directed ultrasound in the area of pain
  • can be on oral contraceptives
05

Study design

Phase
Phase 2 / Phase 3
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double
Enrollment
82 participants (actual)

Interventions

  • DrugVitamin E, Evening Oil of Primrose, and Placebo
06

What researchers measure

Primary outcomes

  1. Test if Vitamin E improves cyclical breast pain

  2. Test if Evening Oil of Primrose improves cyclical breast pain

  3. Test if combination of Evening Oil of Primrose and Vitamin E works synergistically for cyclial breast pain

07

Study locations

1 site
  • Mayo Clinic
    Rochester, Minnesota 55905, United States
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 26, 2009, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT00275600
Lead sponsor
Mayo Clinic
Collaborators
New Health International
First posted
Jan 12, 2006
Start date
Jan 2003
Primary completion
Sep 2007
Completion
Sep 2007
Last update
Nov 26, 2009

Study contacts

Sandhya Pruthi, M.D.
principal investigator · Mayo Clinic
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2009. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion